GRPR and lung carcinoma: Wang and colleagues exploited functionalized hybrid PAMAM dendrimers to target GRPR-positive lung cancer and, likewise, they showed very promising results, including selective absorption in the HEL-299 lung cancer cell line and beneficial retention in tumors in vivo after intratumoral injection [22].